Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...

The court ruled in favor of Novo Nordisk and the FDA, rejecting a compounding pharmacy group's attempt to stop the FDA's ...

The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...

The legal battle over who can make and distribute a weight loss ingredient is brewing, and an Edmond telehealth provider is joining the fight.

INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide ... definitely took advantage of this market to compound products,” said Veronica Vernon, an sssistant ...

PLAINSBORO, N.J., April 14, 2025 /PRNewswire/ -- Novo Nordisk has become aware of several hundred units of Ozempic ® (semaglutide) injection 1 mg distributed outside the Novo Nordisk authorized ...